FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 01/02/2015 |
3. Issuer Name and Ticker or Trading Symbol
WOLVERINE WORLD WIDE INC /DE/ [ WWW ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock(1) | 252,739 | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Stock Option (Right to Buy) | (2) | 02/06/2017 | Common Stock | 23,600 | $15.13 | D | |
Stock Option (Right to Buy) | (3) | 02/05/2018 | Common Stock | 32,000 | $12.53 | D | |
Stock Option (Right to Buy) | (4) | 02/09/2019 | Common Stock | 42,000 | $8.56 | D | |
Stock Option (Right to Buy) | (5) | 02/10/2020 | Common Stock | 30,400 | $12.5 | D | |
Stock Option (Right to Buy) | (6) | 02/08/2021 | Common Stock | 20,800 | $18.25 | D | |
Stock Option (Right to Buy) | (7) | 02/07/2022 | Common Stock | 22,400 | $19.92 | D | |
Stock Option (Right to Buy) | (8) | 02/05/2023 | Common Stock | 25,240 | $21.48 | D | |
Stock Option (Right to Buy) | (9) | 02/10/2024 | Common Stock | 22,123 | $27.13 | D |
Explanation of Responses: |
1. The number of shares reported includes 16,796 restricted shares of common stock granted to the reporting person on February 11, 2014, under the Company's Stock Incentive Plan of 2013. Subject to the Company's achievement of specified performance criteria in accordance with the terms of the grant, restrictions on such shares will lapse in February 2017. In addition, the number of shares reported includes 18,492 and 20,584 restricted shares of common stock granted to the reporting person on February 8, 2012, and February 6, 2013, respectively, under the Company's Stock Incentive Plan of 2010. Subject to the Company's achievement of specified performance criteria in accordance with the terms of the grant, restrictions on 18,492 and 20,584 of such shares will lapse in February 2015 and February 2016, respectively. Any shares as to which restrictions do not lapse at such times will be forfeited. |
2. This option became exercisable as to 7,867 shares on February 7, 2008, as to 7,867 shares on February 7, 2009, and as to 7,866 shares on February 7, 2010. |
3. This option became exercisable as to 10,667 shares on February 6, 2009, as to 10,667 shares on February 6, 2010, and as to 10,666 shares on February 6, 2011. |
4. This option became exercisable as to 14,000 shares on February 10, 2010, as to 14,000 shares on February 10, 2011, and as to 14,000 shares on February 10, 2012. |
5. This option became exercisable as to 10,134 shares on February 10, 2011, as to 10,133 shares on February 10, 2012, and as to 10,133 shares on February 10, 2013. |
6. This option became exercisable as to 6,934 shares on February 9, 2012, as to 6,933 shares on February 9, 2013, and as to 6,933 shares on February 9, 2014. |
7. This option became exercisable as to 7,467 shares on February 8, 2013, and as to 7,466 shares on February 8, 2014, and becomes exercisable as to 7,467 shares on February 8, 2015. |
8. This option became exercisable as to 8,414 shares on February 6, 2014, and becomes exercisable as to 8,413 shares on February 6, 2015, and as to 8,413 shares on February 6, 2016. |
9. This option becomes exercisable as to 7,375 shares on February 10, 2015, as to 7,374 shares on February 10, 2016, and as to 7,374 shares on February 10, 2017. |
Remarks: |
/s/ Timothy E. Foley, by Power of Attorney | 01/12/2015 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |